Patents by Inventor Antonio Vong

Antonio Vong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090076274
    Abstract: Intermediates useful in the preparation of compounds of formula (I) and pharmaceutically acceptable salts thereof are disclosed: wherein A, R1, R2, R3, , p, q, and X are as defined in the specification.
    Type: Application
    Filed: November 12, 2008
    Publication date: March 19, 2009
    Inventors: Barbara Bertani, Manuela Borriello, Andrea Bozzoli, Steven Mark Bromidge, Enrica Granci, Colin Leslie, Halina Serfinowska, Luigi Stasi, Antonio Vong, Valeria Zucchelli
  • Publication number: 20070167423
    Abstract: Compounds of formula (I) and pharmaceutically acceptable salts thereof are provided: wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description. Methods of preparation and uses thereof in therapy, particularly for CNS disorders such as depression or anxiety, are also disclosed.
    Type: Application
    Filed: March 16, 2007
    Publication date: July 19, 2007
    Inventors: Markus Bergauer, Barbara Bertani, Matteo Biagetti, Steven Bromidge, Alessandro Falchi, Colin Leslie, Giancarlo Merlo, Domenica Pizzi, Marilisa Rinaldi, Luigi Stasi, Jessica Tibasco, Antonio Vong, Simon Ward
  • Publication number: 20060264429
    Abstract: Compounds of formula (I) and pharmaceutically acceptable salts thereof are disclosed: wherein A, R1, R2, R3, p, q, A and X are as defined in the specification. Preparation of the compounds and uses in the treatment of CNS and other disorders, including depression and anxiety, are also disclosed.
    Type: Application
    Filed: November 20, 2003
    Publication date: November 23, 2006
    Inventors: Barbara Bertani, Manuela Borriello, Andrea Bozzoli, Steven Bromidge, Enrica Granci, Colin Leslie, Halina Serfinowska, Luigi Stasi, Antonio Vong, Valeria Zucchelli
  • Publication number: 20060229312
    Abstract: Compounds of formula (I) and pharmaceutically acceptable salts thereof are provided: wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description. Methods of preparation and uses thereof in therapy, particularly for CNS disorders such as depression or anxiety, are also disclosed.
    Type: Application
    Filed: July 15, 2004
    Publication date: October 12, 2006
    Inventors: Markus Bergauer, Barbara Bertani, Matteo Biagetti, Steven Bromidge, Alessandro Falchi, Colin Leslie, Giancarlo Merlo, Domenica Pizzi, Marilisa Rinaldi, Luigi Stasi, Jessica Tibasco, Antonio Vong, Simon Ward
  • Publication number: 20050107410
    Abstract: Compounds of formula (I) and pharmaceutically acceptable salts thereof are disclosed: wherein: A is optionally substituted phenyl, naphthyl, indolyl, quinolinyl, quinazolinyl, indazolyl, isoquinolinyl or benzofuranyl; X is carbon, Y is CH and is a double bond; or X is CH, Y is CH2 or oxygen and is a single bond; or X is nitrogen, Y is CH2 and is a single bond; is halogen, hydroxy, cyano, C1-6alkyl, haloC1-6alkyl or C1-6alkoxy; a is 0, 1, 2, 3 or 4; R2 and R3, together with the nitrogen atom to which they are attached, form a nitro group or an optionally substituted 3 to 7 membered heterocyclic group, or R2 and R3 are independently hydrogen, aroyl, C1-6alkyl, C1-6alkanoyl, fluoroC1-6alkanoyl, C1-6alkylsulfonyl, fluoroC1-6alkylsulfonyl, carbamoyl, C1-6alkylcarbamoyl, arylC1-6alkyl or a group CO(CH2)bNR4R5 wherein b is 1, 2, 3 or 4; and R4 and R5 are independently hydrogen or C1-6alkyl, or R4 and R5, together with the nitrogen atom to they are attached, form part of an optionally substituted 3
    Type: Application
    Filed: February 17, 2003
    Publication date: May 19, 2005
    Inventors: Paul Smith, Kevin Thewlis, Antonio Vong, Simon Ward